BML Capital Management, LLC
ZIONSVILLE, IN · CIK 1616824 · 13F filing filed 2026-08-07
Exempt reporting adviser since 2012 · limited liability company
- Private funds1 (1 hedge) · $73.3m gross assets
- Form ADV · 2026-03-25SEC adviser record
- Kindhedge funds
- Others nearbyZionsville, IN
As an employer
- Offices in1 country
- Private fundshedge 1
$175.1m
reported value
+12.7% vs Q1 2026
15positions
93.8%in top 10
1 new
5 added
3 reduced
1 sold out
vs Q1 2026
Options: 0 call positions (— notional), 3 put positions ($954.1k notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ACLARIS THERAPEUTICS INC ACRS | $63.3m36.18% | Reduced -2.3m |
| ATEA PHARMACEUTICALS INC AVIR | $32.3m18.46% | Reduced -106.3k |
| ENGENE THERAPEUTICS INC ENGN | $11.5m6.59% | New |
| KRAFT HEINZ CO KHC | $11.0m6.27% | Added +340.0k |
| OUTSET MED INC OM | $10.9m6.22% | Added +617.5k |
| CARMAX INC KMX | $9.1m5.21% | Added +17.5k |
| TILLYS INC TLYS | $9.0m5.16% | Unchanged |
| PMV PHARMACEUTICALS INC PMVP | $7.1m4.08% | Added +10.0k |
| INSTIL BIO INC TIL | $5.0m2.84% | Unchanged |
| TARGET CORP TGT | $4.9m2.80% | Unchanged |
| ORAMED PHARMACEUTICALS INC ORMP | $4.2m2.38% | Reduced -2.3m |
| JANUX THERAPEUTICS INC JANX | $2.4m1.36% | Unchanged |
| PLIANT THERAPEUTICS INC PLRX | $1.8m1.01% | Unchanged |
| CONNECT BIOPHARMA HLDGS LTD CNTB | $1.4m0.78% | Added +164.4k |
| IMAGENEBIO INC IMA | $1.2m0.68% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| KEZAR LIFE SCIENCES INC KZR | $5.3m720.8k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| WALMART INC WMT · Put | $386.1k335 shares | Unchanged |
| CORE SCIENTIFIC INC NEW CORZ · Put | $298.0k800 shares | New |
| TESLA INC TSLA · Put | $270.0k375 shares | New |